Pyxis Oncology (NASDAQ:PYXS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Pyxis Oncology (PYXS) operate in?

Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 603.32K
Day Range	- - -
52 Wk Range	1.35 - 6.85
Market Cap	$134.39M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	11.96%
Days to Cover	8.59

Recent News

Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside

Stephens initiates coverage on Pyxis Oncology (PYXS), highlighting its promising ADC technology and a $13 price target, with upcoming clinical trial results.

Vandana Singh

Pyxis Oncology, Inc. Reports Q1 Loss, Tops Revenue Estimates

Pyxis Oncology, Inc. (NASDAQ: PYXS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 603.32K
Day Range	- - -
52 Wk Range	1.35 - 6.85
Market Cap	$134.39M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	11.96%
Days to Cover	8.59

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pyxis Oncology (PYXS) stock?

You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.

View our list of the best stock brokerages

Who are Pyxis Oncology (PYXS) competitors?

Other companies in Pyxis Oncology’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the forecast, or price target, for Pyxis Oncology (PYXS) stock?

Pyxis Oncology has a consensus price target of $10.67.

What is the current price for Pyxis Oncology (PYXS)?

The stock price for Pyxis Oncology (NASDAQ: PYXS) is $2.26 last updated November 20, 2024 at 7:59 PM EST.

Does Pyxis Oncology (PYXS) pay a dividend?

There are no upcoming dividends for Pyxis Oncology.

When is Pyxis Oncology (NASDAQ:PYXS) reporting earnings?

Pyxis Oncology’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Pyxis Oncology (PYXS) going to split?

There is no upcoming split for Pyxis Oncology.

What sector and industry does Pyxis Oncology (PYXS) operate in?

Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Pyxis Oncology

Pyxis Oncology (PYXS) Forecast